SGHERZA N, CURCI P, STRAFELLA V, RIZZI R, MUSTO P. Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma. Acta Biomed [Internet]. 2021 May 12 [cited 2024 Nov. 27];92(2):e2021205. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/11395